Physikalische Kartierung von Medaka (Oryzias latipes) by Zadeh Khorasani, Maryam
 1 
 
Physical mapping of 







to obtain the academic degree 
Doctor rerum naturalium (Dr. rer. nat.) 
 
submitted to the Department of Biology, Chemistry and Pharmacy 



























1st Reviewer: Dr. Heinz Himmelbauer 
2nd Reviewer: Prof. Dr. Rupert Mutzel 
 
 






1 PHYSIKALISCHE KARTIERUNG VON MEDAKA (ORYZIAS LATIPES)..................8 
2 INTRODUCTION .................................................................................................................10 
2.1 Teleosts .............................................................................................................................. 10 
2.1.1 Taxonomy................................................................................................................... 11 
2.2 Medaka (Oryzias latipes).................................................................................................. 11 
2.2.1 The history of medaka ................................................................................................ 12 
2.2.2 Geographic variation and strains ................................................................................ 12 
2.2.3 See-through medaka fish............................................................................................ 14 
2.3 Genome study among the teleosts and human provides the knowledge of their 
synteny and phylogeny ................................................................................................................. 15 
2.3.1 Synteny conservation among medaka, zebrafish and human..................................... 15 
2.3.2 Gene duplication in teleost fish.................................................................................. 17 
2.4 Medaka as a genetic tool .................................................................................................. 17 
2.4.1 Medaka genetic and linkage map ............................................................................... 18 
2.4.2 Sex determination....................................................................................................... 19 
2.4.3 Medaka and transgenesis............................................................................................ 21 
2.4.4 ES-like cells................................................................................................................ 22 
2.4.5 Nuclear transplantation in the medaka....................................................................... 23 
2.4.6 Medaka genomic resources ........................................................................................ 24 
2.5 Teleost genome sequencing .............................................................................................. 26 
2.5.1 Zebrafish..................................................................................................................... 27 
2.5.2 Tetraodon nigroviridis ............................................................................................... 28 
2.5.3 Takifugu rubripes ....................................................................................................... 29 
2.5.4 Medaka genome sequencing project .......................................................................... 29 
2.6 Objective ........................................................................................................................... 29 
3 MATERIAL AND METHODS............................................................................................31 
3.1 Equipment......................................................................................................................... 31 
 4 
3.2 Kits ..................................................................................................................................... 32 
3.3 Enzymes............................................................................................................................. 32 
3.4 Chemicals and Substances............................................................................................... 33 
3.5 Other materials................................................................................................................. 34 
3.6 Oligonucleotides ............................................................................................................... 36 
3.6.1 BAC end-fragment primers ........................................................................................ 36 
3.6.2 cDNA primers ............................................................................................................ 36 
3.6.3 35-mer oligonucleotides from medaka expressed sequences..................................... 37 
3.7 Software............................................................................................................................. 37 
3.8 Buffers and reagents ........................................................................................................ 37 
3.8.1 DNA preparation solutions ......................................................................................... 37 
3.8.2 Hybridization solutions .............................................................................................. 38 
3.8.3 Spotting solutions ....................................................................................................... 39 
3.8.4 Other solutions ........................................................................................................... 40 
3.8.5 Media .......................................................................................................................... 42 
3.9 Alkaline lysis maxi preparation of plasmid DNA.......................................................... 44 
3.9.1 Preparation of culture................................................................................................. 44 
3.9.2 DNA preparation........................................................................................................ 44 
3.10 BAC-DNA minipreparation............................................................................................ 45 
3.10.1 Culture preparation..................................................................................................... 45 
3.10.2 DNA isolation ............................................................................................................ 45 
3.11 Purification of closed circular DNA by equilibrium centrifugation in CsCl-ethidium 
bromide gradients ........................................................................................................................ 46 
3.11.1 Preparation of culture and plasmid DNA isolation.................................................... 46 
3.11.2 DNA precipitation...................................................................................................... 46 
3.11.3 DNA purification........................................................................................................ 47 
3.11.4 Removal of ethidium bromide by washing the DNA with isoamylalcohol............... 48 
3.11.5 DNA precipitation and washing................................................................................. 48 
 5 
3.12 Preparation of genomic fish DNA................................................................................... 48 
3.12.1 Determination of DNA concentration........................................................................ 49 
3.13 Digestion............................................................................................................................ 49 
3.13.1 Digestion of BAC DNA for amplification of end fragments..................................... 49 
3.13.2 Digestion of pBluescript II KS (-) vector for ligation................................................ 49 
3.14 Dephosphorylation........................................................................................................... 50 
3.15 Ligation of BAC fragments into a plasmid vector ........................................................ 50 
3.16 Amplification .................................................................................................................... 50 
3.16.1 Amplification of BAC end-fragments........................................................................ 50 
3.16.2 Amplification of cDNA clone inserts......................................................................... 51 
3.17 Purification of PCR-products ......................................................................................... 52 
3.17.1 QIAquick kit-Method ................................................................................................. 52 
3.17.2 Silica Matrix DNA Purification kit (NC001 nuclean I kit) ........................................ 53 
3.18 Bacterial transformation by heat shock ......................................................................... 53 
3.19 Agarose gel electrophoresis ............................................................................................. 53 
3.20 Library replication........................................................................................................... 54 
3.21 Colony filter spotting and processing ............................................................................. 54 
3.21.1 Preparation of filters and robot................................................................................... 54 
3.21.2 Filter processing ......................................................................................................... 56 
3.22 Selection of 35-mer oligonucleotide probes.................................................................... 57 
3.23 Pooling scheme.................................................................................................................. 57 
3.23.1 2D Scheme ................................................................................................................. 58 
3.23.2 3D scheme .................................................................................................................. 58 
3.24 Hybridization.................................................................................................................... 58 
3.24.1 Non-radioactive hybridization with digoxigenin (DIG-dUTP) labeled probes ......... 58 
3.24.2 Radioactive hybridization .......................................................................................... 61 
 6 
3.25 Software tools for constructing a physical map............................................................. 64 
3.25.1 Clustering medaka ESTs for aligning on the fugu genome ....................................... 64 
3.25.2 Image analysis ............................................................................................................ 65 
3.25.3 Pooled Probes Editor (PPE) ....................................................................................... 65 
3.25.4 Wprobeorder............................................................................................................... 65 
4 RESULTS.............................................................................................................................66 
4.1 Creation of BAC end-fragments ..................................................................................... 66 
4.1.1 BAC DNA isolation................................................................................................... 66 
4.2 Amplification .................................................................................................................... 68 
4.3 Hybridization.................................................................................................................... 70 
4.3.1 Hybridization with DIG labeled probes ..................................................................... 70 
4.3.2 Hybridization utilizing the radioactive approach....................................................... 71 
4.4 Creating cDNA fragments ............................................................................................... 71 
4.5 Use of the synteny between medaka and Takifugu rubripes sequence to identify 
probes for mapping ...................................................................................................................... 73 
4.5.1 Medaka EST data clustering and match against fugu genome sequence ................... 75 
4.5.2 Selection of 35-mer oligonucleotides, pooling and hybridization ............................. 76 
4.5.3 Data analysis .............................................................................................................. 81 
4.5.4 Map construction and physical map........................................................................... 85 
5 DISCUSSION.......................................................................................................................88 
5.1 Use of medaka strains for creating a physical map....................................................... 88 
5.2 BAC mapping ................................................................................................................... 89 
5.2.1 BAC-based sequencing in the era of whole genome shotgun.................................... 91 
5.3 Source of probes utilized for map construction............................................................. 91 
5.4 Map construction.............................................................................................................. 93 
 7 
5.5 Medaka LG22 project ...................................................................................................... 94 
5.6 Outlook .............................................................................................................................. 98 
6 SUMMARY........................................................................................................................ 100 
7 REFERENCES.................................................................................................................. 102 
8 LIST OF ABBREVIATIONS ........................................................................................... 114 
9 CURRICULUM VITAE..................................................................................................... 117 
9.1 Publications: ................................................................................................................... 118 
9.2 Acknowledgements ......................................................................................................... 119 
9.3 Statement ......................................................................................................................... 120 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
